ACA
IDXX icon

Atlas Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Atlas Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.3K Buy
+69
New +$38.7K ﹤0.01% 787
2022
Q3 		– Sell
-125
Closed -$43.8K – 955
2022
Q2 		$43.8K Buy
+125
New +$51K 0.01% 584
2018
Q4 		– Sell
-32
Closed -$7.66K – 581
2018
Q3 		$7.66K Buy
+32
New +$7.77K ﹤0.01% 507

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Atlas Capital Advisors's IDXX Position: Q2 2026 in Review

Atlas Capital Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 69 shares worth $36.3K. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings. This is a return to the name: Atlas Capital Advisors previously reported a position in IDXX as recently as Q2 2022.

Atlas Capital Advisors first reported a position in IDXX in Q3 2018 and has held it in 3 quarters since. The position peaked at $43.8K in Q2 2022. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Atlas Capital Advisors held 69 shares of Idexx Laboratories worth $36.3K as of Q2 2026.
  • Idexx Laboratories was a new Atlas Capital Advisors position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #787 holding.
  • Atlas Capital Advisors first reported a position in Idexx Laboratories in Q3 2018 and has held it in 3 quarters since.
  • Atlas Capital Advisors's Idexx Laboratories position peaked at $43.8K in Q2 2022.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.